Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

An annual jab to protect against HIV “shows potential”, according to an early study. Millions of people around the world are ...

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full day of the conference, reports from the ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...